{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:14:53Z","timestamp":1789470893430,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00542","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T05:29:16Z","timestamp":1588051756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma"],"prefix":"10.3389","volume":"10","author":[{"given":"Tae Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong-Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sang","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hee","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Ho","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Myung","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hwan","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/carcin\/bgn113","article-title":"Recent advances in the natural history of hepatocellular carcinoma","volume":"29","author":"Trevisani","year":"2008","journal-title":"Carcinogenesis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3350\/kjhep.2009.15.3.391","article-title":"[Practice guidelines for management of hepatocellular carcinoma 2009]","volume":"15","year":"2009","journal-title":"Korean J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5009\/gnl14460","article-title":"2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma","volume":"9","year":"2015","journal-title":"Gut Liver."},{"key":"B5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1200\/JCO.2017.75.3228","article-title":"Radiofrequency ablation versus stereotactic body radiotherapy for localized hepatocellular carcinoma in nonsurgically managed patients: analysis of the national cancer database","volume":"36","author":"Rajyaguru","year":"2018","journal-title":"J Clin Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.radonc.2018.12.005","article-title":"Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies","volume":"131","author":"Rim","year":"2019","journal-title":"Radiother Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"34","author":"Wahl","year":"2016","journal-title":"J Clin Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3857\/roj.2017.00598","article-title":"Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?","volume":"36","author":"Lee","year":"2018","journal-title":"Radiat Oncol J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.prro.2015.01.004","article-title":"Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: photons versus protons","volume":"5","author":"Gandhi","year":"2015","journal-title":"Pract Radiat Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3109\/0284186X.2015.1009637","article-title":"Normal liver sparing by proton beam therapy for hepatocellular carcinoma: comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy","volume":"54","author":"Kim","year":"2015","journal-title":"Acta Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.meddos.2007.04.008","article-title":"Proton radiotherapy for liver tumors: dosimetric advantages over photon plans","volume":"33","author":"Wang","year":"2008","journal-title":"Med Dosim."},{"key":"B13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.radonc.2016.12.014","article-title":"Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis","volume":"122","author":"Kim","year":"2017","journal-title":"Radiother Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.18632\/oncotarget.23428","article-title":"Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma","volume":"9","author":"Kim","year":"2018","journal-title":"Oncotarget."},{"key":"B15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/cancers11020230","article-title":"Does risk-adapted proton beam therapy have a role as a complementary or alternative therapeutic option for hepatocellular carcinoma?","volume":"11","author":"Kim","year":"2019","journal-title":"Cancers"},{"key":"B16","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00066-014-0643-z","article-title":"Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma","volume":"190","author":"Kim","year":"2014","journal-title":"Strahlenther Onkol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4143\/crt.2013.218","article-title":"Phase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinoma","volume":"47","author":"Kim","year":"2015","journal-title":"Cancer Res Treat."},{"key":"B18","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00066-014-0604-6","article-title":"Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"190","author":"Lee","year":"2014","journal-title":"Strahlenther Onkol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ijrobp.2008.10.073","article-title":"A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma","volume":"74","author":"Fukumitsu","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/cas.13145","article-title":"Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma","volume":"108","author":"Fukuda","year":"2017","journal-title":"Cancer Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1158\/1078-0432.CCR-04-1350","article-title":"Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients","volume":"11","author":"Chiba","year":"2005","journal-title":"Clin Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1200\/JCO.2005.00.620","article-title":"Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma","volume":"23","author":"Kawashima","year":"2005","journal-title":"J Clin Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ijrobp.2016.02.027","article-title":"Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: results of an interim analysis","volume":"95","author":"Bush","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1386-6346(02)00144-4","article-title":"Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis","volume":"24","author":"Ueno","year":"2002","journal-title":"Hepatol Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.radonc.2011.12.008","article-title":"Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma","volume":"104","author":"Takeda","year":"2012","journal-title":"Radiother Oncol."},{"key":"B27","article-title":"Time-dose relationships: the linear-quadrantic approach","volume-title":"Basic Clinical Radiobiology","author":"Joiner","year":"2003"},{"key":"B28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ijrobp.2006.08.015","article-title":"Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy","volume":"67","author":"Kim","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1002\/cncr.25809","article-title":"The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial","volume":"117","author":"Bush","year":"2011","journal-title":"Cancer."},{"key":"B31","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/jgh.12470","article-title":"Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area","volume":"29","author":"Kwak","year":"2014","journal-title":"J Gastroenterol Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"999","DOI":"10.21037\/jgo.2019.08.03","article-title":"Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation","volume":"10","author":"Hasan","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.12.288","article-title":"Local control after stereotactic body radiation therapy for liver tumors","author":"Ohri","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.radonc.2014.11.033","article-title":"Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis","volume":"114","author":"Qi","year":"2015","journal-title":"Radiother Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijrobp.2019.01.076","article-title":"Protons versus photons for unresectable hepatocellular carcinoma: liver decompensation and overall survival","volume":"105","author":"Sanford","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00542\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T05:29:19Z","timestamp":1588051759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00542\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":36,"alternative-id":["10.3389\/fonc.2020.00542"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00542","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"article-number":"542"}}